Members of the GENE Consortium
Click the following links to visit GENE Consortium member websites (links open in a new window)
- Alexion Pharmaceuticals
- Berg Health
- Dimension Therapeutics
- Intellia Therapeutics
- NGM Biopharmaceuticals
As part of the GENE Consortium, these companies will work together on a year-long Industry Trial involving a selection of whole genome sequences across cancer and rare diseases.
Industry engagement will be the most effective way of accelerating the development of new diagnostics and treatments that will ultimately benefit patients. The aim of the Industry Trial is to explore the most effective and secure way of achieving this goal.